Icelandirect Acquires SOMA LABS, Significantly Expanding Dosage Form Manufacturing Capabilities for Human and Pet Supplement Brands
Icelandirect, a portfolio company of New Heritage Capital, has acquired SOMA LABS, a New Jersey-based supplement manufacturer specializing in solid dosage form production. The transaction closed in February 2026. The acquisition is a direct investment in capability — expanding what Icelandirect can build, manufacture, and deliver for its clients across both the human nutrition and
Icelandirect, a portfolio company of New Heritage Capital, has acquired SOMA LABS, a New Jersey-based supplement manufacturer specializing in solid dosage form production. The transaction closed in February 2026. The acquisition is a direct investment in capability — expanding what Icelandirect can build, manufacture, and deliver for its clients across both the human nutrition and